Latest

Neuroscience News

·May 23, 2025·4 min read

Billy Joel Diagnosed with Normal Pressure Hydrocephalus: What is NPH?

Billy Joel has revealed a diagnosis of normal pressure hydrocephalus (NPH), a rare but potentially reversible brain disorder that causes symptoms like gait disturbance, cognitive decline, and urinary incontinence. NPH occurs when cerebrospinal fluid builds up in the brain's ventricles without increased pressure, often mimicking dementia or Parkinson’s.

This shows a person wearing headphones and a brain.

Featured Neuroscience Psychology

·May 18, 2025·4 min read

How Music Can Emotionally Reshape Your Memories

A new neuroscience study reveals that music can alter the emotional content of our memories when played during recollection. Participants who listened to emotionally charged music while recalling neutral stories later remembered those stories with emotional tones matching the music.

Featured Neuroscience Open Neuroscience Articles

·May 5, 2025·5 min read

Out-of-Body Experiences Offer New Clues About Consciousness

Out-of-body experiences (OBEs) are often dismissed as hallucinations or brain malfunctions, but a new study gives voice to those who have lived them. Through in-depth interviews, participants described their OBEs as vivid, often peaceful, and undeniably real—sometimes more real than waking life.

This shows a heart and a couple sitting apart.

Featured Neuroscience Psychology

·September 4, 2023·4 min read

How Dating Myths and Sexism Fuel Online Relationship Violence

The rise of the internet and social media has ushered in a new form of dating violence termed cyber-violence. This form of abuse encompasses acts of control, humiliation, and threats in the online realm.

Featured Neuroscience Psychology

·September 3, 2023·5 min read

Dark Traits, Broken Sleep: How Machiavellianism and Psychopathy Impact Rest

A recent study delves into the link between the Dark Triad personality traits—Machiavellianism, psychopathy, and narcissism—and sleep quality, particularly in individuals with affective disorders (AD). Using data from 657 people, the research reveals that Machiavellianism and psychopathy have a significantly negative impact on sleep quality.

Featured Neuroscience

·May 14, 2023·3 min read

Symphony of Synapses: The Brain’s Intricate Dance with Music

Music engages a multitude of brain areas, showcasing a complex interplay between auditory processing, emotion, and memory centers. It elicits emotions through the release of dopamine, our brain's pleasure molecule, explaining the joy we often find in a favorite tune. Moreover, music's power to evoke vivid memories highlights its connection to the hippocampus, our memory storage center. This broad influence of music on our brain mechanisms is also harnessed in therapeutic contexts, such as treating neurological disorders or improving mental health.

Featured Neuroscience Psychology

·May 13, 2023·4 min read

Emotionally Aware AI: ChatGPT Outshines Humans in Emotional Tests

ChatGPT has shown a significant ability to understand and articulate emotions, according to a recent study. The study employed the Level of Emotional Awareness Scale (LEAS) to evaluate ChatGPT's responses to various scenarios, comparing its performance to general population norms. The AI chatbot not only outperformed the human average but also showed notable improvement over time.

Featured Neuroscience

·May 13, 2023·4 min read

Exercise and the Brain: The Neuroscience of Fitness Explored

The neuroscience of fitness explores how regular exercise profoundly impacts our brain and nervous system. Exercise stimulates neurogenesis - the creation of new neurons - primarily in the hippocampus, influencing memory and learning while increasing key mood-regulating neurotransmitters.

Featured Neurology Neuroscience

·May 3, 2023·3 min read

Alzheimer’s Drug Donanemab Slows Cognitive and Functional Decline in Phase 3 Study

Findings from a Phase 3 study show donanemab significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer's disease. Donanemab met the primary endpoint of change, which measured measures cognition and activities of daily living such as managing finances, driving, engaging in hobbies, and conversing about current events, from baseline until 18 months on the integrated Alzheimer's Disease Rating Scale (iADRS). All secondary endpoints of cognitive and functional decline were also met and showed highly statistically significant clinical benefits with similar magnitude. Results suggest that people in the early pathological stage of Alzheimer's could be the most responsive to therapeutics targeting amyloid.

Featured Genetics Neuroscience

·March 15, 2023·3 min read

Scientists Create Baby Mice from Two Fathers

Using the genetic material from two male mice, researchers were able to successfully create baby mice. The advancement may eventually enable same-sex partners to have their own biological children.